Sanofi Expands Consumer Health Reach In China With Minsheng VMS Joint Venture
This article was originally published in The Pink Sheet Daily
Executive Summary
The deal gives Sanofi direct access to China's "booming" OTC vitamins and supplements segment, which pulled in an estimated $8 billion in retail value sales in 2009 and is growing at a rate of 4 percent in local currency, Euromonitor analysts say.
You may also be interested in...
Unknown Timing of Lovenox Generics Complicates Sanofi-Aventis' Outlook
LONDON - Sanofi-Aventis CEO Chris Viehbacher appeared uncomfortable discussing the expected timing of generic competition to Lovenox (enoxaparin) during a Feb. 10 earnings call
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.